Vizient Center for Pharmacy Practice Excellence
VerifiedRx
Delivering short doses of insight for hospitals’ frontline pharmacists, Vizient pharmacy leader Gretchen Brummel brings together experts to verify best practices for navigating today’s pharmacy practice challenges and accelerating career growth. It’s a prescription for success, delivered by the Vizient Center for Pharmacy Practice Excellence.
Be sure to visit the podcast's website and support the creator: verifiedrx.podbean.com
Author
Vizient Center for Pharmacy Practice Excellence
Category
Podcast website
Latest episode
Oct 27, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
A periop love story: sugamma-next? Or stay with your (neo) ex? 12.10.2021 17:11
The debate on whether to use sugammadex or neostigmine has heated up dramatically in recent years. Two industry experts, Eric Johnson, perioperative critical care pharmacist at UK HealthCare, and Stacy Lauderdale, senior director for drug information at Vizient, discuss the many considerations involved in choosing between the two agents. Guest speakers: Eric Johnson, PharmD, BCCCP Perioperative...
Enhanced Recovery After Colorectal Surgery 14.09.2021 10:17
Historically there have been countless paths to recovery following colorectal surgery. However, having a well-rounded, evidence-based enhanced recovery program is critical to patient success. Two Vizient experts, Mark Ninno and Karen Smethers discuss the details and the power of these programs. Guest speakers: Mark Ninno, PharmD Senior Consulting Solutions Director Vizient Karen Smethers, Pha...
The Unknowns of Anti-factor Xa Reversal: The Experts Weigh In 10.08.2021 15:11
The ability to chronically anticoagulate a patient has prevented significant morbidity and mortality from thromboembolic events. Over time, our anticoagulation choices for oral use have evolved, but the need for reversal agents still persist. Two Vizient pharmaceutical experts weigh in on the clinical implications and latest standings of reversal agents. Guest speaker: Stacy Lauderdale, PharmD,...
Vizient Pharmacy Market Outlook Summer 2021 28.07.2021 11:11
Vizient publishes the Pharmacy Market Outlook twice a year to project drug prices and key market trends for the next 18-months. Pharmacists use this information to budget and project their supply needs. Carina Dolan, Senior Director for Clinical Oncology and Pharmaceutical Outcomes at Vizient shares details revealed in the summer 2021 edition of the Pharmacy Market Outlook. Guest speaker: Car...
Show me the data! Updates on the evidence of thrombolytic use in ischemic strokes 13.07.2021 13:16
Ischemic stroke is the leading cause of morbidity and mortality in the United States, taking the lives of 140,000 people each year. Historically, the thrombolytic alteplase has been the mainstay of drug therapy, but now the FDA is looking at tenecteplase as a treatment option for ischemic strokes. Guest speaker: Philippe Mentler, PharmD, BCPS Consulting Director, Pharmacy Vizient Moderator: G...
The Drug Supply Chain Security Act: The road to patient safety 08.06.2021 14:13
The Drug Supply Chain Security Act was enacted in 2013 to protect patients from counterfeit, stolen or contaminated medications. It allows for the detection and removal of these drugs from the marketplace. In this podcast, we explore how frontline pharmacy staff can support compliance. Guest speaker: Joseph Alessandrini, RPh, FASHP Vice President, Clinical Services Inspira Health Network Moder...
Rattlesnakes, copperheads, cottonmouths, oh my! The antivenins for crotalid envenomation 11.05.2021 10:52
Summertime means snakebite time, and with it comes the critical decisions pharmacists and clinicians are faced with when choosing antivenins. In this episode, we will look at the differences and similarities between the two latest antivenins for snakebites. Guest speaker: Philippe Mentler, PharmD, BCPS Consulting Director, Pharmacy Vizient Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Exe...
Expedited drug reviews in the time of COVID-19 (Part 2) 13.04.2021 9:55
The Coronavirus pandemic has put a spotlight on drug supply and the approval process for new medications. In this episode, we will define the different expedited drug approval processes, and take a closer look at how successful these programs are in identifying drug efficacy. Guest speaker: Steven Lucio, PharmD, BCPS Senior Principal, Pharmacy Solutions Vizient Moderator: Gretchen Brummel, Pha...
Expedited drug reviews in the time of COVID-19 (Part 1) 09.03.2021 13:00
The Coronavirus pandemic has put a spotlight on drug supply and the approval process of new medications. In this episode, we will discuss what frontline pharmacists need to know to about the drug approval process. Guest speaker: Amanda Melton, PharmD, BCPS Senior Clinical Manager Center for Pharmacy Practice Excellence Vizient Moderator: Gretchen Brummel, PharmD, BCPS Pharmacy Executive Direc...
Supply resiliency during unprecedented times 09.02.2021 12:11
The Coronavirus pandemic reveals how vulnerable the drug supply chain can be. In this episode, we will discuss what frontline pharmacists need to know to ensure essential medications are available and the drug supply remains resilient. Guest speakers: Doug Kucera Associate Vice President Contract Services, Pharmacy Vizient Mittal Sutaria, PharmD Vice President Contract and Program Services, Ph...
Staying afloat in rising waters: Resiliency for frontline pharmacy workers 12.01.2021 11:33
The Coronavirus pandemic has taken a toll on clinicians across the country. As the surge persists, staff stressors increase, and the relentless pressure compounds the seriousness of the problem. This episode reveals how the pharmacy director at Capital Health in New Jersey supports his staff and boosts their resiliency. Guest speaker: Daniel T. Abazia, PharmD, BCPS, CPPS Director of Pharmacy...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.